Identification and Characterization of Novel Metabolic Regulators in Mouse and Human Liver

小鼠和人类肝脏中新型代谢调节剂的鉴定和表征

基本信息

  • 批准号:
    9762204
  • 负责人:
  • 金额:
    $ 24.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-08-15 至 2021-07-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract The long non-coding RNAs (lncRNAs) are an emerging and rapidly-growing class of functional genomic elements, and a number have been shown to regulate fundamental biological processes, but the scope of their influence in metabolic disorders remains unknown. Identifying and characterizing metabolically-relevant lncRNAs will be crucial to obtaining a better understanding the pathophysiology of obesity and other diseases of metabolism. The candidate aspires to contribute to this understanding by studying novel metabolic regulators, while developing additional experience in relevant research techniques and receiving the necessary career development training to transition to a role as an independent principal investigator. Expanding on the candidate’s recent genome-wide screen that identified 140 lncRNAs and 239 mRNAs sensitive to metabolic conditions in mouse liver, the proposed research will study the roles of one novel lncRNA, Gm15441, in regulating triglyceride (TG) and cholesterol metabolism (Aim 1) and one novel protein-coding gene, Rab30, in regulating autophagy, free fatty acid (FFA) oxidation, and TG secretion in mouse livers (Aim 2). The mechanism by which Gm15441 regulates TG and cholesterol metabolism will be defined by exploring its cis-regulation of the overlapping metabolically-relevant protein-coding gene. In preliminary experiments, knockdown of Rab30 affected autophagy and lipid metabolism in fasting mouse livers, therefore the role of Rab30 in membrane trafficking will be determined. Additionally, the comprehensive bioinformatics analysis pipeline established in the recent genome-wide screen will be applied to human liver samples, to identify novel lncRNA metabolic regulators in human liver (Aim 3). The efficacy of this pipeline for predicting the function of human genes was established in preliminary experiments by testing known metabolic genes, such as G6PC (glucose-6-phosphatase catalytic subunit), which was correctly predicted to function in gluconeogenesis. A K22 award will offer this candidate the opportunity to develop new skills in CRISPR, confocal microscopy, cell biology, and bioinformatics. The candidate will develop these skills while developing experience in pursuing research of translational significance. Gm15441, for instance, is localized in a region that is syntenic with the human 1q21-23 locus, implicated in type 2 diabetes mellitus and familial combined hyperlipidemia. The candidate has developed a comprehensive plan for the development of her career, has identified coursework that will confer necessary skills for success as an independent investigator, and has secured a team of distinguished mentors and advisors who will support her throughout her career transition. Successful completion of the work described in this proposal could provide critical insight into the regulatory networks of hepatic and systemic metabolism, and will afford the candidate the ability to achieve research independence.
项目摘要/摘要 长的非编码RNA(LNCRNA)是一种新兴且快速增长的功能基因组元素, 并且已经证明有许多可以调节基本生物学过程,但其影响的范围 在代谢障碍中仍然未知。识别和表征与代谢相关的LNCRNA将是 对于更好地了解肥胖症和其他代谢疾病的病理生理学至关重要。 候选人渴望通过研究新型代谢调节剂来为这种理解做出贡献,而 开发有关相关研究技术并获得必要职业的额外经验 发展培训以过渡到独立首席研究员的角色。 扩展候选人最近的全基因组屏幕,该屏幕确定了140个LNCRNA和239个mRNA敏感 对于小鼠肝脏中的代谢条件,拟议的研究将研究一种新型lncrna,GM15441, 在调节甘油三酸酯(TG)和胆固醇代谢(AIM 1)和一种新型蛋白质编码基因Rab30中 调节自噬,游离脂肪酸(FFA)氧化和小鼠生命中的TG分泌(AIM 2)。机制 GM15441通过探索其顺式调节来调节TG和胆固醇代谢 与代谢相关的蛋白质编码基因重叠。在初步实验中,敲除rab30 在禁食小鼠生活中影响自噬和脂质代谢,因此Rab30在膜中的作用 将确定贩运。此外,在 最近全基因组筛查将应用于人肝样品,以鉴定新的LNCRNA代谢调节剂 在人类肝脏中(AIM 3)。该管道预测人类基因功能的效率已建立 在初步实验中,通过测试已知的代谢基因,例如G6PC(葡萄糖-6-磷酸酶催化 亚基),正确预测在糖异生中起作用。 K22奖将为该候选人提供开发CRISPR,共聚焦显微镜,细胞的新技能的机会 生物学和生物信息学。候选人将在发展追求经验的同时发展这些技能 转化意义的研究。例如,GM15441位于与 人类1q21-23基因座,涉及2型糖尿病和家庭组合高脂血症。候选人 为她的职业发展制定了一项全面的计划,已经确定了课程工作 作为独立调查员成功的必要技能,并获得了杰出导师团队 以及将在整个职业生涯过渡中支持她的顾问。成功完成所描述的工作 在这一建议中,可以为肝和系统性代谢的监管网络提供批判性见解, 并将为候选人提供实现研究独立性的能力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ling Yang其他文献

Ling Yang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ling Yang', 18)}}的其他基金

Regulation and Function of Thioredoxin Interacting Protein (Txnip) in Nonalcoholic Steatohepatitis (NASH)
硫氧还蛋白相互作用蛋白 (Txnip) 在非酒精性脂肪性肝炎 (NASH) 中的调节和功能
  • 批准号:
    10736673
  • 财政年份:
    2023
  • 资助金额:
    $ 24.38万
  • 项目类别:
Role of ADH5 in the Regulation of Brown Adipose Tissue Metabolic Homeostasis
ADH5 在棕色脂肪组织代谢稳态调节中的作用
  • 批准号:
    10684223
  • 财政年份:
    2022
  • 资助金额:
    $ 24.38万
  • 项目类别:
Integration of Inflammatory Signaling and the Unfolded Protein Response by Nitrosylation Signaling in Obesity
肥胖中炎症信号传导与亚硝基化信号传导的未折叠蛋白反应的整合
  • 批准号:
    10302313
  • 财政年份:
    2017
  • 资助金额:
    $ 24.38万
  • 项目类别:
Integration of Inflammatory Signaling and the Unfolded Protein Response by Nitrosylation Signaling in Obesity
肥胖中炎症信号传导与亚硝基化信号传导的未折叠蛋白反应的整合
  • 批准号:
    10062953
  • 财政年份:
    2017
  • 资助金额:
    $ 24.38万
  • 项目类别:

相似海外基金

Structural analysis of the human LRRK2
人类 LRRK2 的结构分析
  • 批准号:
    10734733
  • 财政年份:
    2023
  • 资助金额:
    $ 24.38万
  • 项目类别:
Hepatotoxic mechanisms of anti-HIV- and anti-COVID-19 drugs and substance use disorders
抗 HIV 和抗 COVID-19 药物和物质使用障碍的肝毒性机制
  • 批准号:
    10684434
  • 财政年份:
    2023
  • 资助金额:
    $ 24.38万
  • 项目类别:
The Role of DENND5B in Dietary Lipid Absorption
DENND5B 在膳食脂质吸收中的作用
  • 批准号:
    10661074
  • 财政年份:
    2022
  • 资助金额:
    $ 24.38万
  • 项目类别:
Neurodevelopmental Function of TBC1D7: A Core Component of the TSC Complex
TBC1D7 的神经发育功能:TSC 复合体的核心组成部分
  • 批准号:
    10590134
  • 财政年份:
    2022
  • 资助金额:
    $ 24.38万
  • 项目类别:
Dysregulation of iron homeostasis by mutant LRRK2 in human neurons
人类神经元中突变型 LRRK2 导致铁稳态失调
  • 批准号:
    10592478
  • 财政年份:
    2022
  • 资助金额:
    $ 24.38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了